MedTrace Logo

Study of Basivertebral Nerve Ablation Treatment of Chronic Low Back Pain

NCT03266107 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-12-22

Study results available
· View outcomes & findings →

Summary

Prospective, single arm, open label, multi-center study to evaluated the effectiveness of intraosseous basivertebral nerve radiofrequency ablation using the Intracept System.

Conditions

  • Chronic Low Back Pain

Interventions

DEVICE

Intracept

Radiofrequency ablation of the basivertebral nerve using the Intracept System

Sponsors & Collaborators

  • Relievant Medsystems, Inc.

    lead INDUSTRY

Principal Investigators

  • Eeric Truumees, MD · Independent

  • Kevin Macadaeg, MD · Independent

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-14
Primary Completion
2020-02-17
Completion
2020-02-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03266107 on ClinicalTrials.gov